DeepMed Research

HEIDELBERG UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1386-01-01

Employees: -

Market Cap: -

Website: https://www.uni-heidelberg.de/

Clinical Trials

TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors

Phase 2

Terminated

Conditions: Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer

Interventions: Radiation: carbon ion boost

First Posted Date: 2010-11-23

Last Posted Date: 2013-04-24

Lead Sponsor: Heidelberg University

Target Recruit Count: 8

Registration Number: NCT01245985

Locations: 🇩🇪
Dept of Radiation Oncology, University of Heidelberg, Heidelberg, Germany

New Echocardiographic Methods for Right Ventricular Function.

Conditions: Right Ventricular Dysfunction

First Posted Date: 2010-10-29

Last Posted Date: 2016-11-08

Lead Sponsor: Heidelberg University

Target Recruit Count: 150

Registration Number: NCT01230294

Locations: 🇩🇪
University of Heidelberg, Heidelberg, Baden-Wuerttemberg, Germany

EBUS Guided Cryo Biopsy of Solitary Pulmonary Nodules

Not Applicable

Conditions: Yield of Cryo Biopsy in Lung Cancer
Solitary Pulmonary Nodule

Interventions: Procedure: Cryo biopsy

First Posted Date: 2010-10-15

Last Posted Date: 2010-10-15

Lead Sponsor: Heidelberg University

Target Recruit Count: 30

Registration Number: NCT01221493

Locations: 🇩🇪
Department of Pneumology and Critical Care medicine, Heidelberg, BW, Germany

Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)

Phase 2

Completed

Conditions: Sinonasal Malignancies
Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses

Interventions: Radiation: carbon ion boost

First Posted Date: 2010-10-14

Last Posted Date: 2022-09-01

Lead Sponsor: Heidelberg University

Target Recruit Count: 36

Registration Number: NCT01220752

Locations: 🇩🇪
Dept of Radiation Oncology, University of Heidelberg, INF 400, Heidelberg, Germany

Galectin-3 Binding Protein in Cardiovascular Disease and Chronic Heart Failure

Completed

Conditions: Coronary Artery Disease
Heart Failure
Cardiomyopathies

First Posted Date: 2010-09-28

Last Posted Date: 2010-09-28

Lead Sponsor: Heidelberg University

Target Recruit Count: 373

Registration Number: NCT01210157

Locations: 🇩🇪
University of Heidelberg, Dept. of Cardiology, Heidelberg, Germany

Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases

Phase 1

Conditions: Colorectal Liver Metastases

Interventions: Radiation: one time radiation
Radiation: No Radiation

First Posted Date: 2010-08-31

Last Posted Date: 2010-10-22

Lead Sponsor: Heidelberg University

Target Recruit Count: 40

Registration Number: NCT01191632

Locations: 🇩🇪
University of Heidelberg, Heidelberg, Germany

Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy

Phase 1

Conditions: Adenoid Cystic Carcinoma

Interventions: Drug: Cetuximab

First Posted Date: 2010-08-31

Last Posted Date: 2013-04-24

Lead Sponsor: Heidelberg University

Target Recruit Count: 49

Registration Number: NCT01192087

Locations: 🇩🇪
Dept. of Radiation Oncology, Heidelberg, Germany

Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base

Phase 3

Conditions: Chondrosarcoma

Interventions: Radiation: carbon ion therapy
Radiation: proton therapy

First Posted Date: 2010-08-17

Last Posted Date: 2010-08-17

Lead Sponsor: Heidelberg University

Target Recruit Count: 154

Registration Number: NCT01182753

Locations: 🇩🇪
University of Heidelberg, Heidelberg, Im neuenheimer Feld 400, Germany

Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base

Phase 3

Conditions: Chordoma
Tumor
Treatment

Interventions: Radiation: Carbon ion
Radiation: Protons

First Posted Date: 2010-08-17

Last Posted Date: 2010-08-17

Lead Sponsor: Heidelberg University

Target Recruit Count: 319

Registration Number: NCT01182779

Locations: 🇩🇪
University of Heidelberg, Heidelberg, Germany

CO(Mbined Therapy of Malignant) S(Alivary Gland tu)M(Ours With)I(MRT and) c(Arbon Ions): COSMIC

Phase 2

Conditions: Malignancy
Salivary Glands
Tumor

Interventions: Radiation: carbon ion boost

First Posted Date: 2010-06-30

Last Posted Date: 2013-04-24

Lead Sponsor: Heidelberg University

Target Recruit Count: 54

Registration Number: NCT01154270

Locations: 🇩🇪
Dept. of Radiation Oncology, INF 400, Heidelberg, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy